Literature DB >> 12136070

Carbamazepine- induced hypertension.

Nathalie Jette1, Tim Veregin, Alan Guberman.   

Abstract

A 33-year-old man with complex partial seizures developed de novo hypertension after the initiation of carbamazepine, which resolved on discontinuation. Although rare, a variety of cardiovascular effects including hypertension have been reported with carbamazepine. Numerous mechanisms may be responsible; however, shared pharmacologic properties with the tricyclic antidepressants are suspect. Hypertension is a rare side effect of carbamazepine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136070     DOI: 10.1212/wnl.59.2.275

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Resistant hypertension and PRES syndrome induced by carbamazepine in a patient with SLE: A case report and literature review.

Authors:  Mohammad Alsultan; Kassem Basha
Journal:  Ann Med Surg (Lond)       Date:  2022-05-11

Review 2.  Secondary hypertension: interfering substances.

Authors:  Ehud Grossman; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

Review 3.  Cardiometabolic effects of psychotropic medications.

Authors:  Oluchi Abosi; Sneha Lopes; Samantha Schmitz; Jess G Fiedorowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-01-10

4.  Valproate Induced Hypertensive Urgency.

Authors:  Mauran Sivananthan; Sarah Mohiuddin
Journal:  Case Rep Psychiatry       Date:  2016-06-15

Review 5.  Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness.

Authors:  Victor Mazereel; Johan Detraux; Davy Vancampfort; Ruud van Winkel; Marc De Hert
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

6.  Carbamazepine-induced hypertension: A rare case.

Authors:  Preeti Kharb; Niti Mittal; Mahesh C Gupta
Journal:  J Pharmacol Pharmacother       Date:  2015 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.